FDA outlines flexible approaches for artificial pancreas system clinical trials, product approvals
The U.S. Food and Drug Administration today issued draft guidance designed to help investigators and manufacturers as they develop and seek approval for artificial pancreas device systems to treat type 1 diabetes.
